Tamibarotene is an Orally Active RARα Agonist for AML and Other Cancers Research
RARα is a member of the retinoic acid receptor (RAR) family of nuclear hormone receptors....
RARα is a member of the retinoic acid receptor (RAR) family of nuclear hormone receptors....
Acute myeloid leukemia (AML) is a disease along with poor prognosis. AML results from rapid...
FLT3 (Fms-like tyrosine kinase 3, CD135) is a cytokine receptor which belongs to the receptor tyrosine...
Acute Myeloid Leukemia (AML) is a disease of the bone marrow, a disorder of hematopoietic...
Isocitrate dehydrogenase (IDH) is an enzyme that catalyzes the oxidative decarboxylation of isocitrate. Firstly, IDH...
Acute myeloid leukemia (AML) is a group of malignant diseases of the hematopoietic system. And,...
On December 1, 2022, FDA approved Rezlidhea (Olutasidenib) to treat adults with relapsed or refractory...
Acute myeloid leukemia (AML) is clinically and genetically heterogeneous hematopoietic cancer. Leukemia cells are unable...
Acute myeloid leukemia (AML) is a kind of cancer diseases, a cancer of the myeloid...
Isocitrate dehydrogenase (IDH), one of the key enzymes in the citric acid cycle. And it...